GRI Bio GRI
NASDAQ GRI
$1.55 +0.09 (+6.16%)
As of: Oct 21, 2026 · 10:21 AM EDT

GRI Bio (GRI) Non-Current Debt (2020)

Updated

GRI Bio (GRI) reported Non-Current Debt of $14,000 for Q4 2020.

Analysis

GRI Bio (GRI) Non-Current Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.80 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 614.95 Bn 533.47 Bn 17.26 Bn 37.34 Bn
3 AbbVie 505.05 Bn 478.16 Bn 12.70 Bn 62.48 Bn
4 Merck 368.08 Bn 322.46 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.32 Bn 262.31 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.58 Bn 235.26 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.05 Bn 191.45 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.61 Bn 164.80 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.86 Bn 116.50 Bn 10.94 Bn 60.50 Bn
10 GRI Bio 2.80 Mn -31.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 14,000.00
API Access

GRI Bio Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=GRI&period=max&api_key=YOUR_API_KEY